Primary care management of chronic kidney disease

Journal of General Internal Medicine

Volumn 26, Issue 4, 2011, Pages 386-392

  Allen, Adrienne S ^a,b,d   Forman, John P ^a,b,d   Orav, E John ^a,b   Bates, David W ^a,b,c   Denker, Bradley M ^a,b,d   Sequist, Thomas D ^a,b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

chronic kidney disease; performance measurement; primary care; quality of care

Indexed keywords

ALENDRONIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; IBANDRONIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; RISEDRONIC ACID; TERBINAFINE;

ANEMIA; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SAFETY; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC BONE DISEASE; MORTALITY; MULTICENTER STUDY; PRIMARY MEDICAL CARE; PROTEINURIA; RETROSPECTIVE STUDY; RISK MANAGEMENT; URINALYSIS;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE MANAGEMENT; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYSICIANS, PRIMARY CARE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 79953698417     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1523-6     Document Type: Article

References (46)

1. J Coresh E Selvin LA Stevens, et al. 2007 Prevalence of chronic kidney disease in the United States Jama 298 17 2038 2047 17986697 10.1001/jama.298.17. 2038 1:CAS:528:DC%2BD2sXht1yjsLnM (Pubitemid 350074801)
2. K/DOQI 2002 Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl 1 S1 266
3. K/DOQI 2003 Clinical practice guidelines for management of dyslipidemias in patients with kidney disease Am J Kidney Dis 41 4 Suppl 3 S1 91
4. K Matsushita M van der Velde BC Astor, et al. 2010 Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 9731 2073 2081 20483451 10.1016/S0140-6736(10)60674-5
5. AS Levey J Coresh E Balk, et al. 2003 National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2 137 147 12859163
6. K Zandi-Nejad BM Brenner 2005 Strategies to retard the progression of chronic kidney disease Med Clin North Am 89 3 489 509 15755464 10.1016/j.mcna.2004.11.001 (Pubitemid 40332394)
7. R Minutolo L De Nicola G Mazzaglia, et al. 2008 Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy Am J Kidney Dis 52 3 444 453 18468747 10.1053/j.ajkd.2008.03. 002
8. LE Boulware MU Troll BG Jaar DI Myers NR Powe 2006 Identification and referral of patients with progressive CKD: a national study Am J Kidney Dis 48 2 192 204 16860184 10.1053/j.ajkd.2006.04.073 (Pubitemid 44069609)
9. LA Stevens G Fares J Fleming, et al. 2005 Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease J Am Soc Nephrol 16 8 2439 2448 15930090 10.1681/ASN.2005020192 (Pubitemid 41725062)
10. CH Fox A Brooks LE Zayas W McClellan B Murray 2006 Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study J Am Board Fam Med 19 1 54 61 16492006 10.3122/jabfm.19.1.54 (Pubitemid 44046994)
11. JP Lea WM McClellan C Melcher E Gladstone T Hostetter 2006 CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis 47 1 72 77 16377387 10.1053/j.ajkd.2005.09.027 (Pubitemid 41828268)
12. CL Tseng EF Kern DR Miller, et al. 2008 Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease Arch Intern Med 168 1 55 62 18195196 10.1001/archinternmed.2007.9
13. MD Philipneri LA Rocca Rey MA Schnitzler, et al. 2008 Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review Clin Exp Nephrol 12 1 41 52 18175059 10.1007/s10157-007-0016-3
14. PE Stevens DJ O'Donoghue S de Lusignan, et al. 2007 Chronic kidney disease management in the United Kingdom: NEOERICA project results Kidney Int 72 1 92 99 17440495 10.1038/sj.ki.5002273 1:STN:280:DC%2BD2sznvFWgtA%3D%3D (Pubitemid 47014451)
15. R Minutolo FC Sasso P Chiodini, et al. 2006 Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings J Hypertens 24 8 1655 1661 16877970 10.1097/01.hjh.0000239303.93872.31 1:CAS:528:DC%2BD28XnsVOlu7w%3D (Pubitemid 44162469)
16. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group Ann Intern Med 130 6 461 470 10075613 1:CAS:528:DyaK1MXitFChs7k%3D (Pubitemid 29135798)
17. National Committee For Quality Assurance Web Site. HEDIS and quality measurement. http://www.ncqa.org/tabid/59/Default.aspx. Accessed September, 14, 2010.
18. KDOQI 2007 Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease Am J Kidney Dis 49 2 Suppl 2 S12 154
19. SF Dinneen HC Gerstein 1997 The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature Arch Intern Med 157 13 1413 1438 9224218 10.1001/archinte.157.13. 1413 1:STN:280:DyaK2szmslGitw%3D%3D
20. HC Gerstein JF Mann Q Yi, et al. 2001 Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals Jama 286 4 421 426 11466120 10.1001/jama.286.4.421 1:CAS:528:DC%2BD3MXlvFKksL0%3D (Pubitemid 32681484)
21. CH Fox A Swanson LS Kahn K Glaser BM Murray 2008 Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research Network (UNYNET) Study J Am Board Fam Med 21 6 522 530 18988719 10.3122/jabfm.2008.06.080042
22. A Akbari PJ Swedko HD Clark, et al. 2004 Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program Arch Intern Med 164 16 1788 1792 15364673 10.1001/archinte.164.16.1788 (Pubitemid 39215649)
23. M Rutkowski W Mann S Derose, et al. 2009 Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente Am J Kidney Dis 53 3 Suppl 3 S86 99 19231766 10.1053/j.ajkd.2008.07.052
24. AS Go GM Chertow D Fan CE McCulloch CY Hsu 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 1296 1305 15385656 10.1056/NEJMoa041031 1:CAS:528:DC%2BD2cXnvFSgtr8%3D (Pubitemid 39268908)
25. DH Smith CM Gullion G Nichols DS Keith JB Brown 2004 Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population J Am Soc Nephrol 15 5 1300 1306 15100370 10.1097/01.ASN.0000125670. 64996.BB (Pubitemid 38526011)
26. NI Parikh SJ Hwang MG Larson JB Meigs D Levy CS Fox 2006 Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control Arch Intern Med 166 17 1884 1891 17000946 10.1001/archinte.166.17.1884 (Pubitemid 44455172)
27. JJ Snyder AJ Collins 2009 KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004 Am J Nephrol 30 1 44 54 19202328 10.1159/000201014
28. R Minutolo L De Nicola P Zamboli, et al. 2005 Management of hypertension in patients with CKD: differences between primary and tertiary care settings Am J Kidney Dis 46 1 18 25 15983953 10.1053/j.ajkd.2005.03.019 (Pubitemid 40848429)
29. T Hoy M Fisher B Barber R Borker B Stolshek W Goodman 2007 Adherence to K/DOQI practice guidelines for bone metabolism and disease Am J Manag Care 13 11 620 625 17988187 (Pubitemid 350106951)
30. MV Rocco 2009 Disease management programs for CKD patients: the potential and pitfalls Am J Kidney Dis 53 3 Suppl 3 S56 63 19231762 10.1053/j.ajkd.2008. 07.058
31. TD Sequist GM Fitzmaurice R Marshall, et al. 2010 Cultural competency training and performance reports to improve diabetes care for black patients: a cluster randomized, controlled trial Ann Intern Med 152 1 40 46 20048271
32. C Wyatt V Konduri J Eng R Rohatgi 2007 Reporting of estimated GFR in the primary care clinic Am J Kidney Dis 49 5 634 641 17472845 10.1053/j.ajkd.2007. 02.258 (Pubitemid 46654491)
33. Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. Jama. 303(5);423-429.
34. WC Winkelmayer RJ Glynn R Levin WF Owen Jr J Avorn 2001 Determinants of delayed nephrologist referral in patients with chronic kidney disease Am J Kidney Dis 38 6 1178 1184 11728948 10.1053/ajkd.2001.29207 1:STN:280: DC%2BD3Mnot1Wqug%3D%3D (Pubitemid 34193101)
35. DC Mendelssohn BT Kua PA Singer 1995 Referral for dialysis in Ontario Arch Intern Med 155 22 2473 2478 7503607 10.1001/archinte.155.22.2473 1:STN:280:DyaK28%2FpsV2itA%3D%3D
36. O'Hare AM, Hailpern SM, Pavkov ME, et al. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Arch Intern Med. 170(11):930-936.
37. R Foy S Hempel L Rubenstein, et al. 2010 Meta-analysis: effect of interactive communication between collaborating primary care physicians and specialists Ann Intern Med 152 4 247 258 20157139
38. GM Chertow J Lee GJ Kuperman, et al. 2001 Guided medication dosing for inpatients with renal insufficiency JAMA 286 22 2839 2844 11735759 10.1001/jama.286.22.2839 1:STN:280:DC%2BD3MjgtVGlsw%3D%3D (Pubitemid 33126926)
39. A Jain A Atreja CM Harris M Lehmann J Burns J Young 2005 Responding to the rofecoxib withdrawal crisis: a new model for notifying patients at risk and their health care providers Ann Intern Med 142 3 182 186 15684206 (Pubitemid 40189110)
40. N Rodondi T Peng AJ Karter, et al. 2006 Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus Ann Intern Med 144 7 475 484 16585661 (Pubitemid 46780670)
41. TV Patel AK Singh 2009 Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions Semin Nephrol 29 2 105 112 19371801 10.1016/j.semnephrol.2009.01.003 1:CAS:528: DC%2BD1MXlvVahtL4%3D
42. EF Unger AM Thompson MJ Blank R Temple 2010 Erythropoiesis-stimulating agents-time for a reevaluation N Engl J Med 362 3 189 192 20054037 10.1056/NEJMp0912328 1:CAS:528:DC%2BC3cXosV2iug%3D%3D
43. K/DOQI 2004 Clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease Am J Kidney Dis 43 5 Suppl 1 S1 290
44. AV Chobanian GL Bakris HR Black, et al. 2003 The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report Jama 289 19 2560 2572 12748199 10.1001/jama.289.19.2560 1:CAS:528:DC%2BD3sXjvFCqtrk%3D (Pubitemid 37430158)
45. L Appel JT Wright T Greene, et al. 2010 Intensive blood-pressure control in hypertensive chronic kidney disease N Eng J Med 363 10 918 927 10.1056/NEJMoa0910975 1:CAS:528:DC%2BC3cXhtFWjsbzN
46. TH Jafar PC Stark CH Schmid, et al. 2003 Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis Ann Intern Med 139 4 244 252 12965979 1:CAS:528:DC%2BD3sXnt12kurs%3D